TGFB1 and breast carcinoma: Anti-inflammatory M2-TAMs secrete the cytokine TGF-β, which decreases the TCA cycle metabolic enzyme succinate dehydrogenase (SDH) and results in the accumulation of succinate in human breast cancer cells.